• Consensus Rating: Moderate Buy
  • Consensus Price Target: $104.22
  • Forecasted Upside: 21.13%
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 4 Buy Ratings
  • 1 Strong Buy Ratings
$86.04
▲ +0.81 (0.95%)

This chart shows the closing price for GL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Globe Life Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GL

Analyst Price Target is $104.22
▲ +21.13% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Globe Life in the last 3 months. The average price target is $104.22, with a high forecast of $160.00 and a low forecast of $65.00. The average price target represents a 21.13% upside from the last price of $86.04.

This chart shows the closing price for GL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 9 investment analysts is to moderate buy stock in Globe Life. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/21/2023
  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/21/2023
  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/20/2023
  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/18/2023
  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/16/2024
  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/15/2024
  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/14/2024
  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/14/2024

Latest Recommendations

  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/10/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$62.00 ➝ $65.00Low
6/28/2024Jefferies Financial GroupBoost TargetHold ➝ Hold$85.00 ➝ $88.00Low
6/28/2024Piper SandlerLower TargetOverweight ➝ Overweight$110.00 ➝ $105.00Low
6/26/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$83.00 ➝ $86.00Low
5/21/2024Raymond JamesReiterated RatingStrong-BuyLow
4/24/2024Piper SandlerLower TargetOverweight ➝ Overweight$130.00 ➝ $110.00Low
4/24/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$132.00 ➝ $108.00Low
4/24/2024Truist FinancialLower TargetHold ➝ Hold$125.00 ➝ $80.00Low
4/24/2024Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$130.00 ➝ $110.00Low
4/12/2024Truist FinancialReiterated RatingHold ➝ Hold$125.00Low
4/12/2024Evercore ISILower TargetIn-Line ➝ In-Line$125.00 ➝ $75.00Low
4/11/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$146.00 ➝ $132.00Low
4/10/2024Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$135.00 ➝ $130.00Low
4/5/2024Piper SandlerLower TargetOverweight ➝ Overweight$143.00 ➝ $130.00Low
3/14/2024Evercore ISILower TargetIn-Line ➝ In-Line$138.00 ➝ $125.00Low
2/9/2024Truist FinancialBoost TargetHold ➝ Hold$115.00 ➝ $125.00Low
2/8/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$133.00 ➝ $136.00Low
11/15/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$131.00 ➝ $132.00Low
10/31/2023Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$122.00 ➝ $137.00Low
10/23/2023Raymond JamesBoost TargetStrong-Buy ➝ Strong-Buy$138.00 ➝ $160.00Low
10/6/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$131.00 ➝ $132.00Low
9/14/2023Jefferies Financial GroupBoost TargetHold ➝ Hold$115.00 ➝ $118.00Low
8/18/2023Morgan StanleyUpgradeUnderweight ➝ Equal Weight$131.00Low
8/2/2023Morgan StanleyReiterated RatingUnderweight ➝ Underweight$131.00Low
7/28/2023Piper SandlerBoost Target$130.00 ➝ $131.00Low
5/5/2023Piper SandlerLower Target$135.00 ➝ $130.00Low
4/25/2023Wells Fargo & CompanyInitiated CoverageEqual Weight$120.00Low
4/12/2023Morgan StanleyLower TargetUnderweight$133.00 ➝ $129.00Low
3/14/2023Raymond JamesLower TargetStrong-Buy$141.00 ➝ $138.00Low
2/24/2023Morgan StanleyBoost TargetUnderweight$132.00 ➝ $133.00Low
2/15/2023Raymond JamesBoost TargetStrong-Buy$138.00 ➝ $141.00Low
2/3/2023Truist FinancialBoost TargetHold$112.00 ➝ $125.00Low
1/10/2023Morgan StanleyBoost TargetUnderweight$115.00 ➝ $132.00Low
1/6/2023JPMorgan Chase & Co.Boost TargetOverweight$112.00 ➝ $126.00Low
12/20/2022Piper SandlerBoost TargetOverweight$127.00 ➝ $130.00Low
12/19/2022Credit Suisse GroupBoost TargetOutperform$130.00 ➝ $140.00Low
11/17/2022Morgan StanleyBoost TargetUnderweight$112.00 ➝ $115.00Low
11/1/2022Piper SandlerBoost Target$127.00Low
10/28/2022Truist FinancialBoost TargetHold$100.00 ➝ $112.00Low
10/27/2022Morgan StanleyBoost TargetUnderweight$110.00 ➝ $112.00Low
9/21/2022Raymond JamesInitiated CoverageStrong-Buy$138.00Low
8/17/2022Morgan StanleyBoost TargetUnderweight$109.00 ➝ $110.00Low
7/11/2022JPMorgan Chase & Co.Boost Target$108.00 ➝ $112.00N/A
7/8/2022Piper SandlerBoost TargetOverweight$119.00 ➝ $121.00N/A
6/15/2022Evercore ISIUpgradeIn-Line ➝ Outperform$105.00 ➝ $112.00High
2/22/2022Morgan StanleyBoost TargetUnderweight$105.00 ➝ $107.00Medium
1/25/2022Jefferies Financial GroupInitiated CoverageHold$106.00Low
1/21/2022Wolfe ResearchInitiated CoverageUnderperform$85.00Medium
1/12/2022Piper SandlerUpgradeNeutral ➝ Overweight$105.00 ➝ $117.00High
1/7/2022Morgan StanleyBoost TargetUnderweight$103.00 ➝ $105.00Medium
1/5/2022Piper SandlerBoost TargetUnderweight ➝ Underweight$97.00 ➝ $105.00Medium
11/18/2021Morgan StanleyLower TargetUnderweight$105.00 ➝ $103.00Low
10/19/2021Credit Suisse GroupLower TargetOutperform$135.00 ➝ $130.00Low
7/8/2021Piper SandlerLower TargetNeutral$105.00 ➝ $100.00High
6/7/2021Credit Suisse GroupBoost TargetOutperform$122.00 ➝ $135.00Low
5/19/2021Morgan StanleyBoost TargetUnderweight$100.00 ➝ $105.00Low
4/5/2021JPMorgan Chase & Co.Boost TargetCautious ➝ Overweight$99.00 ➝ $103.00Low
4/1/2021Morgan StanleyBoost TargetUnderweight$95.00 ➝ $100.00Medium
2/25/2021Morgan StanleyBoost TargetUnderweight$93.00 ➝ $95.00Medium
1/15/2021Morgan StanleyBoost TargetUnderweight$92.00 ➝ $93.00Low
1/6/2021Piper SandlerBoost TargetNeutral$87.00 ➝ $95.00N/A
12/4/2020Credit Suisse GroupBoost TargetOutperform$109.00 ➝ $122.00Medium
11/18/2020Morgan StanleyBoost TargetUnderweight$86.00 ➝ $92.00Medium
10/22/2020JPMorgan Chase & Co.Boost TargetOverweight$97.00 ➝ $99.00High
10/22/2020Morgan StanleyBoost TargetUnderweight$84.00 ➝ $86.00High
10/6/2020Morgan StanleyBoost TargetUnderweight$82.00 ➝ $84.00Medium
8/20/2020Morgan StanleyBoost TargetUnderweight$80.00 ➝ $82.00Medium
8/12/2020Credit Suisse GroupReiterated RatingBuyLow
7/23/2020Credit Suisse GroupReiterated RatingBuyLow
7/23/2020Morgan StanleyBoost TargetUnderweight$78.00 ➝ $80.00High
7/6/2020Morgan StanleyBoost TargetUnderweight$72.00 ➝ $78.00High
7/2/2020Piper SandlerLower TargetNeutral$87.00 ➝ $77.00High
6/5/2020Piper SandlerInitiated CoverageNeutral$87.00High
4/24/2020SunTrust BanksLower TargetHold$108.00 ➝ $79.00Low
4/23/2020Morgan StanleyLower TargetUnderweight$73.00 ➝ $72.00Medium
3/17/2020Morgan StanleyLower TargetUnderweight$91.00 ➝ $73.00High
1/7/2020BarclaysReiterated RatingSell$84.00Low
10/10/2019UBS GroupLower TargetSell$85.00 ➝ $84.00Low
9/20/2019Credit Suisse GroupInitiated CoverageOutperform$114.00Low
(Data available from 7/15/2019 forward)

News Sentiment Rating

0.30 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 12 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/18/2023
  • 14 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
1/17/2024
  • 24 very positive mentions
  • 29 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
2/16/2024
  • 25 very positive mentions
  • 22 positive mentions
  • 7 negative mentions
  • 4 very negative mentions
3/17/2024
  • 19 very positive mentions
  • 50 positive mentions
  • 13 negative mentions
  • 5 very negative mentions
4/16/2024
  • 31 very positive mentions
  • 61 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
5/16/2024
  • 20 very positive mentions
  • 59 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
6/15/2024
  • 13 very positive mentions
  • 57 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/15/2024

Current Sentiment

  • 13 very positive mentions
  • 57 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Globe Life logo
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole, term, and other life insurance products; Medicare supplement and supplemental health insurance products, such as accident, cancer, critical illness, heart, and intensive care plans; and single-premium and flexible-premium deferred annuities. The company sells its products through its direct to consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
Read More

Today's Range

Now: $86.04
Low: $85.15
High: $86.78

50 Day Range

MA: $83.06
Low: $77.84
High: $89.49

52 Week Range

Now: $86.04
Low: $38.95
High: $132.00

Volume

636,300 shs

Average Volume

2,019,079 shs

Market Capitalization

$7.75 billion

P/E Ratio

8.22

Dividend Yield

1.12%

Beta

0.81

Frequently Asked Questions

What sell-side analysts currently cover shares of Globe Life?

The following Wall Street analysts have issued reports on Globe Life in the last twelve months: Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Piper Sandler, Raymond James, StockNews.com, Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for GL.

What is the current price target for Globe Life?

9 Wall Street analysts have set twelve-month price targets for Globe Life in the last year. Their average twelve-month price target is $104.22, suggesting a possible upside of 21.1%. Raymond James has the highest price target set, predicting GL will reach $160.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $65.00 for Globe Life in the next year.
View the latest price targets for GL.

What is the current consensus analyst rating for Globe Life?

Globe Life currently has 4 hold ratings, 4 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for GL.

What other companies compete with Globe Life?

How do I contact Globe Life's investor relations team?

Globe Life's physical mailing address is 3700 South Stonebridge Drive, McKinney TX, 75070. The company's listed phone number is (972) 569-4000 and its investor relations email address is [email protected]. The official website for Globe Life is www.globelifeinsurance.com. Learn More about contacing Globe Life investor relations.